| RS2153228310 |
BAP1
|
Health Risk |
Pathogenic |
BAP1-related tumor predisposition syndrome, BAP1-related tumor predisposition syndrome |
| RS2153228333 |
BAP1
|
Health Risk |
Pathogenic |
BAP1-related tumor predisposition syndrome, BAP1-related tumor predisposition syndrome |
| RS2153228340 |
BAP1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2153228345 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, BAP1-related tumor predisposition syndrome |
| RS2153228349 |
BAP1
|
Health Risk |
Pathogenic |
— |
| RS2153228352 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS2153228507 |
BAP1
|
Health Risk |
Pathogenic |
BAP1-related tumor predisposition syndrome, BAP1-related tumor predisposition syndrome |
| RS2153228515 |
BAP1
|
Health Risk |
Pathogenic |
BAP1-related tumor predisposition syndrome, BAP1-related tumor predisposition syndrome |
| RS2153228520 |
BAP1
|
Health Risk |
Pathogenic |
BAP1-related tumor predisposition syndrome, BAP1-related tumor predisposition syndrome |
| RS2153228522 |
BAP1
|
Health Risk |
Pathogenic |
BAP1-related tumor predisposition syndrome, BAP1-related tumor predisposition syndrome |
| RS2153228535 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder, BAP1-related tumor predisposition syndrome |
| RS2153228558 |
BAP1
|
Health Risk |
Likely pathogenic |
BAP1-related tumor predisposition syndrome, BAP1-related tumor predisposition syndrome |
| RS2153228616 |
BAP1
|
Health Risk |
Likely pathogenic |
BAP1-related tumor predisposition syndrome, BAP1-related tumor predisposition syndrome |
| RS2153228628 |
BAP1
|
Health Risk |
Pathogenic |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS2153228637 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS2153228682 |
BAP1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Kury-Isidor syndrome |
| RS2153228693 |
BAP1
|
Health Risk |
Pathogenic/Likely pathogenic |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS2153228694 |
BAP1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, BAP1-related tumor predisposition syndrome |
| RS2153231721 |
CACNA1C
|
Health Risk |
Likely pathogenic |
Timothy syndrome, Timothy syndrome |
| RS2153272667 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy |
| RS2153275538 |
NRCAM
|
Health Risk |
Pathogenic |
NRCAM-related disorder, Neurodevelopmental disorder with neuromuscular and skeletal abnormalities |
| RS2153276539 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, See cases |
| RS2153276574 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153279702 |
UFSP2
|
Health Risk |
Pathogenic |
Spondyloepimetaphyseal dysplasia, di rocco type |
| RS2153283460 |
SLC25A3
|
Health Risk |
Pathogenic |
— |
| RS2153287079 |
SLC25A3
|
Health Risk |
Likely pathogenic |
— |
| RS2153299187 |
SLC39A13
|
Health Risk |
Likely pathogenic |
— |
| RS2153305991 |
PDE4D
|
Health Risk |
Likely pathogenic |
— |
| RS2153306243 |
RAPSN
|
Health Risk |
Pathogenic |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 11 |
| RS2153308170 |
RAPSN
|
Health Risk |
Pathogenic/Likely pathogenic |
Fetal akinesia deformation sequence 2, Congenital myasthenic syndrome |
| RS2153308410 |
RAPSN
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 11, Fetal akinesia deformation sequence 1 |
| RS2153309050 |
RAPSN
|
Health Risk |
Pathogenic/Likely pathogenic |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 11 |
| RS2153309143 |
RAPSN
|
Health Risk |
Pathogenic |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 11 |
| RS2153309845 |
TMEM126B
|
Health Risk |
Pathogenic |
— |
| RS2153311231 |
RAPSN
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myasthenic syndrome 11, Fetal akinesia deformation sequence 1 |
| RS2153311290 |
RAPSN
|
Health Risk |
Pathogenic/Likely pathogenic |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 11 |
| RS2153311310 |
RAPSN
|
Health Risk |
Pathogenic |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 11 |
| RS2153311780 |
RAPSN
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 11, Fetal akinesia deformation sequence 1 |
| RS2153313250 |
TMEM126A
|
Health Risk |
Likely pathogenic |
— |
| RS2153320686 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153341328 |
CNNM4
|
Health Risk |
Pathogenic |
— |
| RS2153341719 |
CNNM4
|
Health Risk |
Pathogenic |
— |
| RS2153344866 |
PDE4D
|
Health Risk |
Likely pathogenic |
— |
| RS2153349278 |
CNNM4
|
Health Risk |
Pathogenic |
Jalili syndrome, Jalili syndrome |
| RS2153351643 |
CNNM4
|
Health Risk |
Likely pathogenic |
— |
| RS2153352800 |
BRCA1
|
Health Risk |
Pathogenic |
Malignant tumor of breast, Malignant tumor of breast |
| RS2153352893 |
BRCA1
|
Health Risk |
Pathogenic |
Malignant tumor of breast, Malignant tumor of breast |
| RS2153353204 |
BRCA1
|
Health Risk |
Pathogenic |
Carcinoma of colon, Breast-ovarian cancer |
| RS2153353304 |
BRCA1
|
Health Risk |
Pathogenic |
— |
| RS2153353848 |
AARS2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 8, Combined oxidative phosphorylation defect type 8 |
| RS2153353988 |
AARS2
|
Health Risk |
Likely pathogenic |
— |
| RS2153354335 |
AARS2
|
Health Risk |
Pathogenic |
— |
| RS2153355216 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153355304 |
AARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined oxidative phosphorylation defect type 8, Combined oxidative phosphorylation defect type 8 |
| RS2153355427 |
AARS2
|
Health Risk |
Likely pathogenic |
— |
| RS2153356880 |
AARS2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 8, Combined oxidative phosphorylation defect type 8 |
| RS2153356902 |
AARS2
|
Health Risk |
Likely pathogenic |
Combined oxidative phosphorylation defect type 8, Combined oxidative phosphorylation defect type 8 |
| RS2153357308 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2153358198 |
AARS2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2153358441 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2153369022 |
NRCAM
|
Health Risk |
Pathogenic |
NRCAM-related disorder, NRCAM-related disorder |
| RS2153386052 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153393425 |
PDE4D
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2153409815 |
SYNE1
|
Health Risk |
Likely pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS2153437998 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153440081 |
CACNA1C
|
Health Risk |
Pathogenic/Likely pathogenic |
Timothy syndrome, Long QT syndrome |
| RS2153440093 |
CACNA1C
|
Health Risk |
Likely pathogenic |
— |
| RS2153447342 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS2153447885 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153452355 |
NEB
|
Health Risk |
Likely pathogenic |
— |
| RS2153453236 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153453450 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153456779 |
SYNE1
|
Health Risk |
Likely pathogenic |
Abnormal central motor function, Abnormal central motor function |
| RS2153458564 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153465555 |
SYNE1
|
Health Risk |
Pathogenic |
— |
| RS2153469119 |
IKZF1
|
Health Risk |
Pathogenic |
Acute lymphoid leukemia, Acute lymphoid leukemia |
| RS2153475495 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153477560 |
IKZF1
|
Health Risk |
Likely pathogenic |
Acute lymphoid leukemia, Acute lymphoid leukemia |
| RS2153477674 |
IKZF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pancytopenia due to IKZF1 mutations, Pancytopenia due to IKZF1 mutations |
| RS2153477847 |
IKZF1
|
Health Risk |
Likely pathogenic |
Pancytopenia due to IKZF1 mutations, Acute lymphoid leukemia |
| RS2153489310 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2153501340 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153501353 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153501416 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153501467 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, type 4 |
| RS2153501643 |
COL3A1
|
Health Risk |
Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Ehlers-Danlos syndrome |
| RS2153501731 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, type 4 |
| RS2153501733 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153501801 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy |
| RS2153501864 |
COL3A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153501869 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153501942 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153501969 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153501973 |
COL3A1
|
Health Risk |
Pathogenic |
— |
| RS2153501976 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153502051 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153502094 |
COL3A1
|
Health Risk |
Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Ehlers-Danlos syndrome |
| RS2153502163 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS2153502168 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, Ehlers-Danlos syndrome |
| RS2153502271 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |